Your Article Summary
See Latest ArticlesPrefilament tau species as potential targets for immunotherapy for Alzheimer disease and related disorders
Current Opinion in Immunology, 06/22/09
Kayed R et al. - Considerable effort over the last decade has been directed toward the development of vaccines for AD; these have been primarily directed against the A beta peptide, a component of senile plaques. More recently, alternative approaches have begun to target the microtubule binding protein tau, a component of neurofibrillary tangles. Immunotherapies based upon oligomeric species of tau represent a promising new approach for AD.
Related Articles
Does Diabetes Speed Up Memory Loss In Alzheimers Disease?
ScienceDaily, 10/28/09
Relevance Score: 71%
High Blood Pressure Likely in Alzheimers Offspring
MedLinePlus, 11/04/09
Relevance Score: 70%
Activated astrocytes: a therapeutic target in Alzheimer's disease?
Expert Review of Neurotherapeutics, 11/19/09
Relevance Score: 69%
Protective Role For Copper In Alzheimers Disease
ScienceDaily, 10/14/09
Relevance Score: 69%
All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease
Expert Review of Neurotherapeutics, 11/19/09
Relevance Score: 68%
Today in Neurologic/Ophthalmic...keeping you current
Receive free subspecialty "5-minute updates" via email
Methylprednisolone inhibits IFN-gamma and IL-17 expression and production by cells infiltrating central nervous system in experimental autoimmune encephalomyelitis
Journal of Neuroinflammation, 12/16/09
Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease
Journal of Neuroinflammation, 12/14/09
Beta-Defensins 2 and 3 Together Promote Resistance to Pseudomonas aeruginosa Keratitis
Journal of Immunology, 12/10/09
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study
Breast Cancer Research and Treatment, 12/17/09
Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine
New England Journal of Medicine, 12/16/09
A Novel Influenza A (H1N1) Vaccine in Various Age Groups
New England Journal of Medicine, 12/16/09